Table 5.

Fourteen cases of non-remission in SLE-CH patients after supplementary treatment

Time	6 m	9 m	12 m
24 h urine protein	1.43 ± 0.42	0.59 ± 0.24**	0.23 ± 0.21**
FT3	3.65 ± 0.79	3.78 ± 0.83	3.81 ± 0.85
FT4	12.89 ± 3.42	13.90 ± 3.52	13.46 ± 3.78
TSH	5.25 ± 1.47	1.72 ± 0.83**	1.35 ± 0.76**
ESR	46.42 ± 11.8	19.5 ± 8.6**	13.1 ± 8.5**
CRP	8.64 ± 4.37	4.47 ± 1.53**	3.56 ± 1.46**
C3	0.36 ± 0.41	0.68 ± 0.36*	0.86 ± 0.33**
SLEDAI	6.38 ± 3.46	1.23 ± 0.53**	0.93 ± 0.31**
PGA	56.77 ± 18.57	21.43 ± 9.25**	12.48 ± 7.63**
SLICC	4.7 ± 1.5	0.8 ± 0.3**	0.6 ± 0.4**
CR, n (%)		9 (64.2)	12 (85.7)Δ

^*P < 0.05 (vs. not treatment);

^**P < 0.01 (vs. not treatment);

^ΔP < 0.05 (vs. SLE-ES 6 m CR).